Our Approach

Our Approach

Our leadership team is comprised of passionate experts in product development, regulatory, clinical, quality, and commercial strategy who bring decades of medical device and cardiovascular experience and a track record of success in developing life-changing healthcare solutions.
We lead with a thoughtful, yet fearless approach to reimagining a world in which ADHF patients and those who care for them can achieve better outcomes.

Reprieve Cardiovascular, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of more than 25 million heart failure patients around the world. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.

Leadership Team

Marc Pacyna Headshot

Mark Pacyna

Chief Executive Officer

Tony Fields Headshot

Tony Fields

Chief Operating Officer

Andrew Halpert Headshot

Andrew Halpert

Vice President of R&D

Cassie Morris Headshot

Cassie Morris

Vice President of Strategy and Innovation

Laura Rudeen Headshot

Laura Rudeen

Director of Clinical Affairs

Kenneth Luppi Headshot

Kenneth Luppi

Director of Operations

Jacob Davis Headshot

Jacob Davis

Director of Quality

Don Hefner Headshot

Don Hefner

Field Clinical Director

Board of Directors

James Eadie

Managing Director

Jan Garfinkle

Founder & Managing Partner

Hanson Gifford


David Neustaedter

Venture Partner

Ethan Benovitz

Innovation Partner

Mark Pacyna

Chief Executive Officer